Business Context and Reporting Period
This Form 8-K is filed by Marathon Patent Group, Inc. (not MARA Holdings, Inc.) for the reporting period of July 16, 2015. The company is incorporated in Nevada and maintains its principal executive offices in Los Angeles, California. The filing reports the entry into a material definitive agreement regarding debt restructuring.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures. The primary financial event disclosed is the restructuring of a Promissory Note issued on October 10, 2014. Key terms include:
- Debt Extension: The maturity date of the Note has been extended to October 1, 2015.
- Interest Accrual: Interest on the Note will accrue starting from May 13, 2015.
- Equity Issuance: The Company agreed to issue 200,000 shares of restricted common stock to the lender (MedTech Development, LLC).
- Prepayments: The Company agreed to make mandatory prepayments under certain circumstances.
Material Changes
The material change reported is the execution of a forbearance agreement with MedTech Development, LLC. This agreement modifies the original terms of the October 2014 Promissory Note by extending the repayment timeline and adding an equity component (200,000 shares) to the debt obligation. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the implications of the debt restructuring. The issuance of the 200,000 shares was deemed exempt from registration under Section 4(a)(2) of the Securities Act of 1933. The full text of the agreement is intended to be filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2015, with potential confidential treatment for certain terms.
Investor Verification Checklist
- Verify the total principal amount and accrued interest of the Promissory Note dated October 10, 2014.
- Confirm the specific conditions triggering the mandatory prepayments mentioned in the forbearance agreement.
- Review the upcoming Form 10-Q (due after September 30, 2015) for the full text of the agreement and any confidential terms.
- Assess the impact of the 200,000 share issuance on existing shareholder dilution.
- Clarify the discrepancy between the requested company name (MARA Holdings, Inc.) and the filing registrant (Marathon Patent Group, Inc.).